Free Trial

CONSUMER STAPLES: Scandinavian Tobacco; Q3 Results

CONSUMER STAPLES

(STGDC; Baa3/NR) 

It is now guiding to leverage moving outside its target (net 2.7x vs. 2.5x) and we do see that in Moody's downgrade threshold. Not necessarily bad news for €29s that have a 1.25% coupon step-up on HY ratings (BBB/BB index is only spread 92bps). The 29s were a cheap view of ours in primary and have performed well (-42bps vs. €IG +2, both against swap). Similar to then we don't see strong positive catalyst ahead but standalone valuation (trades +90 wide of the widest among majors) and step-up protection together may be enough carry for some. As we said in primary please size risk to scale of co; this is €1b in sales vs. majors doing €10-30b - and that is before accounting for lower margins (ex. Imperial majors do 40-handle on EBITDA vs. STG running low 20s - dragged on by labour intensive hand-made cigars).

Keep reading...Show less
334 words

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.

(STGDC; Baa3/NR) 

It is now guiding to leverage moving outside its target (net 2.7x vs. 2.5x) and we do see that in Moody's downgrade threshold. Not necessarily bad news for €29s that have a 1.25% coupon step-up on HY ratings (BBB/BB index is only spread 92bps). The 29s were a cheap view of ours in primary and have performed well (-42bps vs. €IG +2, both against swap). Similar to then we don't see strong positive catalyst ahead but standalone valuation (trades +90 wide of the widest among majors) and step-up protection together may be enough carry for some. As we said in primary please size risk to scale of co; this is €1b in sales vs. majors doing €10-30b - and that is before accounting for lower margins (ex. Imperial majors do 40-handle on EBITDA vs. STG running low 20s - dragged on by labour intensive hand-made cigars).

Keep reading...Show less